Company Email Format Management

enGene

Biotechnology Research Boston, Massachusetts, United States 131 employees ENGN

Employees: 131
Contacts: 3
Emails: 3
Phones: 1

engene.com LinkedIn Crunchbase

enGene Overview

Headquarters: Boston, Massachusetts, United States
Phone Number: Available in AeroLeads
Website: engene.com
Industry: Biotechnology Research
Employees: 131
Founded: 1999
Stock Symbol: ENGN
Funding: 43.2M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

gene-based immunotherapy urology oncology NMIBC non-muscle invasive bladder cancer bladder cancer DNA RNA genetic medicines mucosal tissues non-viral gene therapy drug development

About enGene

enGene (Nasdaq: ENGN) is a clinical-stage biotechnology company aiming to mainstream gene-based immunotherapy by advancing non-viral treatments that can be delivered locally to the site of disease—starting with non-muscle invasive bladder cancer (NMIBC) and expanding beyond. Founded in Canada, with a United States headquarters located in Boston, we are developing innovative solutions with the goal of reducing treatment burden and improving patient outcomes. To learn more about enGene visit our website: enGene.com. We are currently enrolling select patients with NMIBC in our LEGEND clinical trial. We have sites in the United States, Canada, Europe and the Asia-Pacific region. For more information, please visit TheLegendStudy.com.

enGene Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

enGene Org Chart

Sample employees and titles

Name	Title	Location	Contact
Sarah Orr		Greater Boston, United States	Email Phone
Matthew Boyd		United States	Email
Kathleen (Kathy) Richton	Finance Leader - Fp&a - Strategic	Hingham, Massachusetts, United States	View
Gerry Brunk	Managing Director at Lumira Ventures	Greater Boston, United States	Email